Pentagon's senior leadership cuts raise concerns over diversity and politicization of the military.
Henry Schein misses Q1 revenue, but KKR takes stake, influencing board composition amid operational challenges.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
Pentagon's senior leadership cuts raise concerns over diversity and politicization of the military.
Henry Schein misses Q1 revenue, but KKR takes stake, influencing board composition amid operational challenges.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.